Zhou Xiaolan, executive vice president and president of Commercial Operations China for Bayer Pharmaceuticals, and president of Bayer Group (Greater) China

China achieved a year-on-year growth rate of 9.8 percent in the first three quarters of this year, injecting "China momentum" into the global economy.

Bayer firmly supports China's determination to promote economic globalization and opening-up, and we have full confidence in the Chinese market going forward. As one of the multinational companies entering China in the early days, Bayer's vision of "Health for All, Hunger for None" perfectly fits with China's major national strategic goals of "Healthy China", "Rural Revitalization" and "Common Prosperity". China has become one of the most important pillars of Bayer's global business, being the largest market for Bayer Pharmaceuticals and the second largest market for Bayer Consumer Health.

Bayer has been glad to witness the success of the CIIE over the four iterations, having participated since the first expo opened in 2018. This year, Bayer will once again showcase our leading portfolio in healthcare and agriculture at CIIE, highlighting our commitment to creating a better life for Chinese people. We are looking forward to making persistent progress during the 14th Five-Year Plan period and elevating our business in China to the next level.